Missed Opportunities for HPV Vaccination in Adolescent Girls: A Qualitative Study

Missed Opportunities for HPV Vaccination in Adolescent Girls: A Qualitative Study
复制标题

DOI:
10.1542/peds.2014-0442
复制
发表时间:
2014-09-01
期刊:
影响因子:
8
通讯作者:
Pierre-Joseph, Natalie
Pierre-Joseph, Natalie
中科院分区:
医学2区
文献类型:
--
作者:
Perkins, Rebecca B.;Clark, Jack A.;Pierre-Joseph, Natalie

文献摘要

被引文献

相似文献

目的:本研究的目的是确定的理由,由父母/监护人和供应商推迟或管理人乳头瘤病毒(HPV)疫苗接种到girls.METHODS:定性访谈进行了陪同他们的疫苗合格的11- 17岁的女儿到医疗访问的父母/监护人。在1家公共诊所和3家私人诊所进行了访谈,以确定女孩接受或不接受HPV疫苗接种的原因。问卷调查从家长/监护人和供应商的角度探讨疫苗决策。结果:共有124名家长/监护人和37名供应商参与。据报道,父母不给女儿接种疫苗的最常见原因是缺乏医生的建议(44%)。父母和提供者都认为HPV疫苗接种提供了重要的健康益处,但与性活动相关的疫苗接种时机是与疫苗延迟相关的重要主题。自我报告接种率较低的提供者推迟了被认为性活动风险低的女孩的疫苗建议,一些父母报告说,他们的提供者建议或支持推迟接种疫苗,直到他们的女儿长大。然而,父母/监护人和提供者一致认为,预测初次性行为的时间是非常困难的。相比之下,疫苗接种率高的供应商提出HPV疫苗接种作为一种常规疫苗,已被证明是安全的,以防止癌症,和父母积极回应这些messages.CONCLUSIONS:虽然大多数家长和供应商认为,HPV疫苗接种是重要的,错过的机会,从假设接种疫苗的时间相对于性活动。专家建议HPV疫苗接种作为癌症预防,在11岁时与其他疫苗共同接种可以提高疫苗接种率。
OBJECTIVE: The goal of this study was to identify the rationale by parents/guardians and providers for delaying or administering human papillomavirus (HPV) vaccination to girls.METHODS: Qualitative interviews were conducted with parents/guardians accompanying their vaccine-eligible 11- to 17-year-old daughters to medical visits. Interviews were conducted in 1 public clinic and 3 private practice settings to ascertain why girls did or did not receive HPV vaccination. Questions probed vaccine decision-making from the point of view of parents/guardians and providers.RESULTS: A total of 124 parents/guardians and 37 providers participated. The most common reasons parents reported for not vaccinating their daughters was the lack of a physician recommendation (44%). Both parents and providers believed that HPV vaccination provided important health benefits, but the timing of vaccination with relation to sexual activity was an important theme related to vaccine delay. Providers with lower self-reported vaccination rates delayed vaccine recommendations in girls perceived to be at low risk for sexual activity, and several parents reported that their providers suggested or supported delaying vaccination until their daughters were older. However, parents/guardians and providers agreed that predicting the timing of sexual debut was extremely difficult. In contrast, providers with high vaccination rates presented HPV vaccination as a routine vaccine with proven safety to prevent cancer, and parents responded positively to these messages.CONCLUSIONS: Although most parents and providers believe that HPV vaccination is important, missed opportunities result from assumptions about the timing of vaccination relative to sexual activity. Routinely recommending HPV vaccination as cancer prevention to be coadministered with other vaccines at age 11 years can improve vaccination rates.